£490.00

It has never been this cheap. We have no record of a lower price.

£490 today · cheaper than every other day in the last 3 months

Prostate Cancer Nuclear Medicine Diagnostics Outlook 2023-2028

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 22 days · 22 data points (no recent data)

Historical
Generating forecast…
£490.00 £465.50 £475.30 £485.10 £494.90 £504.70 £514.50 03 August 2026 08 August 2026 13 August 2026 18 August 2026 24 August 2026
View at Amazon ↗

Price data last checked 69 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 22 days • 1 price levels

Days at Price
22 days 0 6 11 17 22 £490 Days at Price

Price Analysis

Most common price: £490 (22 days, 100.0%)

Price range: £490 - £490

Price levels: 1 different prices over 22 days

Description

This specialized study provides a comprehensive analysis of the latent demand outlook for prostate cancer nuclear medicine diagnostics from 2023 to 2028. Covering the United States, the report delivers potential industry earnings (P.I.E.) estimates for 10,833 different zip codes. By providing specific data for each zip code, the study allows users to understand the percent share a location holds relative to its state and the entire country. These comparative benchmarks help professionals quickly gauge specific zip codes against others. This statistical approach serves as a valuable tool for sales and distribution teams looking to identify market opportunities and evaluate regional demand across the United States.

Key Features

Provides latent demand outlooks for prostate cancer nuclear medicine diagnostics across the United States from 2023 to 2028.

Includes potential industry earnings (P.I.E.) estimates for 10,833 specific US zip codes.

Reports the percent share for each zip code in relation to its state and the United States as a whole.

Offers comparative benchmarks to help users quickly gauge one zip code against others.

Delivers a statistical approach useful for distribution and sales professionals.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 January 2023
Listed Since
27 January 2023

Similar Products You Might Like

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in China
99% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in China

£495.00 20 Aug 2026
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in Japan
99% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in Japan

£495.00 29 Oct 2026
The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in the United States
98% match

The 2023-2028 Outlook for Prostate Cancer Nuclear Medicine Diagnostics in the United States

£520.00 28 Oct 2026
Prostate Cancer Nuclear Medicine Diagnostics India Outlook
98% match

Prostate Cancer Nuclear Medicine Diagnostics India Outlook

£515.00 30 Oct 2026
The 2025-2030 World Outlook for Prostate Cancer Nuclear Medicine Diagnostics
98% match

The 2025-2030 World Outlook for Prostate Cancer Nuclear Medicine Diagnostics

Price unavailable
The 2025-2030 World Outlook for Prostate Cancer Treatments and Prevention
97% match

The 2025-2030 World Outlook for Prostate Cancer Treatments and Prevention

Price unavailable
The 2025-2030 World Outlook for Prostate Cancer Treatments
97% match

The 2025-2030 World Outlook for Prostate Cancer Treatments

Price unavailable
Prostate Cancer Therapeutics in Africa 2013-2018 Outlook
97% match

Prostate Cancer Therapeutics in Africa 2013-2018 Outlook

£325.00 03 Sep 2026
Hormone Therapy for Prostate Cancer Outlook 2023-2028
97% match

Hormone Therapy for Prostate Cancer Outlook 2023-2028

£490.00 20 Aug 2026
The 2016-2021 Outlook for Prostate Cancer Therapeutics in Japan
97% match

The 2016-2021 Outlook for Prostate Cancer Therapeutics in Japan

£595.00 23 Sep 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in Japan
96% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in Japan

£495.00 20 Aug 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in China
96% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in China

£495.00 31 Oct 2026
US Cancer Screening Outlook 2023-2028 - Zip Code Study
96% match

US Cancer Screening Outlook 2023-2028 - Zip Code Study

£490.00 24 Aug 2026
The 2023-2028 Outlook for Cancer Testing-Screening for US Zip Codes
96% match

The 2023-2028 Outlook for Cancer Testing-Screening for US Zip Codes

£490.00 01 Oct 2026
US Cancer Diagnostics Lab Test Outlook 2023-2028 Study
96% match

US Cancer Diagnostics Lab Test Outlook 2023-2028 Study

£490.00 24 Aug 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in India
96% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in India

£515.00 15 Aug 2026
The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in the United States
96% match

The 2023-2028 Outlook for Hormone Therapy for Prostate Cancer Therapeutics in the United States

£520.00 20 Aug 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes
95% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics for US Zip Codes

£490.00 02 Oct 2026
Breast Cancer Diagnostic Products Outlook 2023-2028 Report
95% match

Breast Cancer Diagnostic Products Outlook 2023-2028 Report

£490.00 20 Aug 2026
Non-Small Cell Lung Cancer Outlook 2023-2028 US Zip Codes
95% match

Non-Small Cell Lung Cancer Outlook 2023-2028 US Zip Codes

£490.00 26 Aug 2026
The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing for US Zip Codes
95% match

The 2023-2028 Outlook for Women's Diagnostic Breast Cancer Testing for US Zip Codes

£490.00 03 Oct 2026
Imaging and Focal Therapy of Early Prostate Cancer (Current Clinical Urology)
95% match

Imaging and Focal Therapy of Early Prostate Cancer (Current Clinical Urology)

Springer

£109.99 20 Sep 2026
Prostate Cancer: Advancements in the Pathogenesis, Diagnosis and Personalized Therapy
95% match

Prostate Cancer: Advancements in the Pathogenesis, Diagnosis and Personalized Therapy

Springer

£129.07 18 Sep 2026
Head and Neck Cancer Outlook 2023-2028 - US Zip Code Study
95% match

Head and Neck Cancer Outlook 2023-2028 - US Zip Code Study

£490.00 26 Aug 2026